Komori
Tsubakimoto Kogyo (8052) · TargetAdvanced

Expansion into Growth Fields such as the Environment, Pharmaceuticals and Regenerative Medicine

First written in FY2016. 13 of 28 entries say "Restated". Latest entry: 2026-05-08.

28entries
11years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2020-Q1 – FY2022-Q32016: 320162017: 320172018: 220182019: 420192020: 320202021: 320212022: 320222023: 320232024: 220242025: 120252026: 1
Same theme, other companies
Business Creation through the Selection of Priority Growth and Development AreasA theme 103 companies write about · 0 as a headwind · 108 as a tailwind

56 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 103 companies compared. The sentences above are computed from all 103.
Full recordFilings, disclosures and news, newest first
  1. 2026-05-08AdvancedEarnings

    「Across industry generally, we will actively propose automation and labor-saving solutions and expand sales of environmental equipment and other products in an effort to win orders and further increase sales.」

    Expansion into growth areas was made specific through proposals for automation and labor-saving solutions and expanded sales of environmental equipment.
  2. FY2025AdvancedAnnual report

    「With a view to restructuring our business portfolio, we will focus on logistics, healthcare, the environment, food, transport infrastructure and EV-related fields as growth areas, while seeking to create new businesses and develop new products. In addition, we will explore business opportunities based on anticipated growth in demand for decarbonization-related products, responding to changes in customer needs accompanying the transition to a decarbonized society.」

    Expansion into growth areas has been defined more specifically as restructuring the business portfolio, creating new businesses, developing new products and exploring decarbonization-related opportunities.
  3. FY2025-H1SoftenedAnnual report

    「In the materials business, revenue declined as demand, mainly for nursing care and hygiene-related products, remained soft.」

    Demand for nursing care and hygiene-related products associated with expansion into growth areas weakened, resulting in lower sales in the Materials Business.
  4. FY2024RaisedAnnual report

    「4. Exploring business opportunities in a decarbonized society We will explore business opportunities based on anticipated growth in demand for decarbonization-related products resulting from changes in customer needs accompanying the transition to decarbonization, including renewable energy, environmental conservation, EVs and hydrogen.」

    The company's conventional exploration of growth areas has been defined more specifically as exploring business opportunities related to decarbonization, including renewable energy, environmental conservation, EVs and hydrogen.
  5. FY2024-Q2SoftenedAnnual report

    「In the materials business, sales of nursing care and hygiene-related products remained at approximately the same level as the year-earlier period as COVID-related demand reached a plateau.」

    Sales of nursing care and hygiene-related products related to growth areas remained at approximately the previous year's level as COVID-related demand ran its course, slowing from the previous trend of recovery and growth.
  6. FY2024-Q1RestatedAnnual report

    「In the materials business, sales remained solid, mainly for nursing care and hygiene-related products.」

    The company continues to explain that sales of nursing care and hygiene-related products associated with expansion into growth areas are performing solidly.
  7. FY2023-Q3AdvancedAnnual report

    「In the materials business, sales increased, mainly for nonwoven fabrics and other products for nursing care and hygiene-related products. Meanwhile, sales activities for overseas tea packaging machines and other products aimed at customers in Europe and North America were restricted by COVID-19 and the situation in Ukraine, resulting in weak activity.」

    Sales of nonwoven fabrics and other nursing care and hygiene-related products associated with growth areas increased, while constraints on products sold overseas due to infectious diseases and the situation in Ukraine continued.
  8. FY2023-Q2AdvancedAnnual report

    「In the Materials Business, sales of nonwoven fabrics and other products for nursing care and hygiene-related applications increased.」

    Sales of nonwoven fabrics and other nursing care and hygiene-related products associated with growth areas progressed from the recovery trend seen through the previous quarter to an increase.
  9. FY2022RaisedAnnual report

    「We will focus on developing new products in a wide range of fields, including growth areas such as the environment, logistics and food, as well as fields that contribute to addressing SDGs and ESG issues.」

    The company has expanded the areas targeted for growth to the environment, logistics and food, and has specified the development of products that contribute to addressing SDGs and ESG issues.
  10. FY2022-Q3RestatedAnnual report

    「In the materials business, sales of nonwoven fabrics and other products for nursing care and hygiene-related products are on a recovery trend, but overseas tea packaging machines and other products continue to be affected by activity restrictions resulting from the spread of COVID-19.」

    The recovery in sales of nonwoven fabrics and other products related to growth areas, as well as the continuing impact of activity restrictions on products sold overseas, have been reconfirmed.
  11. FY2022-Q2RestatedAnnual report

    「In the materials business, sales of nonwoven fabrics and other products for nursing care and hygiene-related products are on a recovery trend, but overseas tea packaging machines and other products continue to be affected by activity restrictions resulting from the spread of COVID-19.」

    Among products related to growth areas, sales of nonwoven fabrics and other products continue to recover, while tea packaging machines and other products sold overseas continue to be affected by infectious diseases.
  12. FY2022-Q1Some growth-area products recovered, while the impact on products sold overseas continued.Annual report

    「In the materials business, sales of nonwoven fabrics and other products for nursing care and hygiene-related products are on a recovery trend. Overseas tea packaging machines and other products continue to be affected by activity restrictions resulting from the spread of COVID-19.」

    Nonwoven fabrics and other products related to growth areas entered a recovery trend, while tea packaging machines and other products sold overseas continue to be affected by activity restrictions.
  13. FY2021-Q3RestatedAnnual report

    「In the materials business, sales of nonwoven fabrics and other products for nursing care and hygiene-related products remained solid, but tea packaging machines and other products sold overseas were significantly affected by activity restrictions resulting from the spread of COVID-19.」

    Among products related to growth areas, nonwoven fabrics and other products remain solid, while tea packaging machines and other products sold overseas continue to be affected by infectious diseases.
  14. FY2021-Q2RestatedAnnual report

    「In the materials business, sales of nonwoven fabrics and other products for nursing care and hygiene-related products remained solid, but tea packaging machines and other products sold overseas were significantly affected by activity restrictions resulting from the spread of COVID-19.」

    Among products related to growth areas, nonwoven fabrics and other products remained solid, while tea packaging machines and other products sold overseas were affected by infectious diseases.
  15. FY2021-Q1Some growth-area products remained solid, while others struggled.Annual report

    「In the materials business, sales of nonwoven fabrics and other products for nursing care and hygiene-related products remained solid, but tea packaging machines and other products sold overseas were significantly affected by activity restrictions resulting from the spread of COVID-19.」

    Nursing care and hygiene-related products performed solidly, but products sold overseas were affected by activity restrictions caused by infectious diseases.
  16. FY2020-Q3RestatedAnnual report

    「In the materials business, sales of nonwoven fabrics and other products for nursing care and hygiene-related products remain solid.」

    Continues to explain that sales of nonwoven fabrics and other nursing care and hygiene-related products associated with expansion into growth areas remain solid.
  17. FY2020-Q2RestatedAnnual report

    「In the materials business, sales of nonwoven fabrics for nursing care and hygiene-related products, tea packaging machines and other products are increasing steadily.」

    Continues to demonstrate sales growth in nursing care and hygiene-related products, nonwoven fabrics, tea packaging machines and other items associated with expansion into growth areas.
  18. FY2020-Q1RestatedAnnual report

    「In the materials business, sales of nonwoven fabrics for nursing care and hygiene-related products, tea packaging machines and other products are increasing steadily.」

    Continues to demonstrate sales growth in nursing care and hygiene-related products, nonwoven fabrics, tea packaging machines and other items associated with expansion into growth areas.
  19. FY2019AdvancedAnnual report

    「In the current consolidated fiscal year, overseas subsidiaries achieved a substantial recovery in both net sales and profit compared with the previous fiscal year, as capital investment demand in each country gradually recovered and proactive sales proposals proved effective. In the Materials Business, sales of nonwoven fabrics for nursing care and hygiene-related products, tea packaging machines and other products also grew steadily. In the Control and Sensing Business, inquiries increased following participation in trade shows, leading steadily to sales. Total net sales for these businesses amounted to ¥18,626 million, or 115.9% of the previous fiscal year's level.」

    The full-year results showed a recovery in overseas subsidiaries' sales and profit, growth in sales of nursing care and hygiene-related products and tea packaging machines, and the conversion of Control and Sensing inquiries into sales. The Development Strategy Division reported net sales of ¥18,626 million, or 115.9% of the previous fiscal year's level.
  20. FY2019-Q3RestatedAnnual report

    「In the Materials Business, sales of nursing care and hygiene-related products, tea packaging machines and other products are also growing steadily.」

    Continues to demonstrate sales growth in nursing care and hygiene-related products and other items associated with expansion into growth areas.
  21. FY2019-Q1RestatedAnnual report

    「Meanwhile, in the materials business, sales of nursing care and hygiene-related products, tea packaging machines and other products are increasing.」

    Continues to demonstrate sales growth in nursing care and hygiene-related products in connection with expansion into promising markets.
  22. FY2018RaisedAnnual report

    「We will focus on expanding business by strengthening promotional activities centered on product proposals, including IoT and image-processing systems, for industries with strong investment appetite in response to labor shortages and for labor-saving solutions, such as distribution, food, transportation infrastructure equipment and environmental facilities, while also strengthening cooperation with supplier manufacturers.」

    In addition to the previously identified growth areas such as the environment and pharmaceuticals, the company has expanded its scope to product proposals, including IoT and image-processing systems, for distribution, food, transportation infrastructure and environmental facilities.
  23. FY2018-Q2AdvancedAnnual report

    「Meanwhile, in the materials business, sales of nursing care and hygiene-related products, tea packaging machines and other products are increasing.」

    In connection with expansion into previously identified promising markets, the company reported higher sales of nursing care and hygiene-related products.
  24. FY2017ReframedAnnual report

    「In the Technomaterial business, expand the business domain by proposing applications for new products in promising markets such as medical care, pharmaceuticals, hygiene, energy and machine tools.」

    The company's expansion into growth areas such as the environment, renewable energy, pharmaceuticals and regenerative medicine has been reorganized under the framework of proposing applications in promising markets in the Technomaterial business.
  25. FY2017-Q3RestatedAnnual report

    「We will also pursue new product development and expanded sales activities in fields such as the environment and renewable energy, pharmaceuticals, regenerative medicine and biotechnology, which are industries expected to grow, and will advance the initiatives below.」

    The company continues to position the environment and renewable energy, pharmaceuticals, regenerative medicine and biotechnology as growth areas for new product development and expanded sales activities.
  26. FY2017-Q2RestatedAnnual report

    「We will also pursue new product development and expanded sales activities in fields such as the environment and renewable energy, pharmaceuticals, regenerative medicine and biotechnology, which are industries expected to grow, and will advance the initiatives below.」

    The company continues to position the environment and renewable energy, pharmaceuticals, regenerative medicine and biotechnology as growth areas for new product development and expanded sales activities.
  27. FY2017-Q1RestatedAnnual report

    「⑦ Expand sales activities in new technologies such as automotive technology, as well as in the environment and renewable energy, pharmaceuticals, regenerative medicine, biotechnology and other promising industries, by continuing customer-development activities across the group.」

    The company reiterates its plan to expand sales activities in growth areas such as the environment and renewable energy, pharmaceuticals, regenerative medicine and biotechnology.
  28. FY2016First statedAnnual report

    「We will also pursue new product development and expanded sales activities in fields such as the environment and renewable energy, pharmaceuticals, regenerative medicine and biotechnology, which are industries expected to grow, and will advance the initiatives below.」

    The company has identified multiple industries expected to grow as targets for new product development and expanded sales activities.
Moved together

"Expansion of Products Handled and Development of New Products" moved the same way as this thread, in the same document, in 10 of its 28 moves.

1087766★123456
  1. ★This thread
  2. 1Expansion of Products Handled and Development of New Products10×
  3. 2Product Development Anticipating Demand for Labor Saving and Workforce Reduction8×
  4. 3A consolidated payout ratio of at least 30% and stable dividends7×
  5. 4Foreign Exchange Risk in Foreign-Currency Transactions and Overseas Subsidiaries7×
  6. 5Strengthening the Domestic Sales Base Through Area Strategies6×
  7. 6Expansion of Overseas Business Centered on East Asia and Southeast Asia6×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Tsubakimoto Kogyo's next results are scheduled for 2026-10-30. Read the earnings preview It last moved in the Earnings of 2026-05-08: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Expansion into Growth Fields such as the Environment, Pharmaceuticals and Regenerative Medicine | TSUBAKIMOTO KOGYO CO.,LTD. (8052) | Komori